Phasic and sustained fear are pharmacologically dissociable in rats

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Previous research indicates distinct neuroanatomical bases for short- versus long-duration fear responses.
• This study investigates whether phasic (short-duration) and sustained (long-duration) fear can also be differentiated pharmacologically.

Purpose of the Study:

• To pharmacologically dissociate phasic and sustained fear responses in rats.
• To evaluate the efficacy of specific anxiolytic and non-anxiolytic drugs on these fear responses.
• To validate the use of sustained fear models for anxiety research and drug screening.

Main Methods:

• Rats were exposed to short (phasic) or long (sustained) duration auditory stimuli paired with footshock.
• Acoustic startle amplitude was measured after drug administration (chlordiazepoxide, buspirone, fluoxetine) or vehicle.
• Drugs were administered acutely or chronically (fluoxetine).

Main Results:

• Chlordiazepoxide selectively blocked sustained fear responses, not phasic ones.
• Acute buspirone disrupted phasic fear but not sustained fear.
• Chronic fluoxetine blocked sustained fear and inconsistently reduced phasic fear; acute fluoxetine had no effect.

Conclusions:

• Phasic and sustained fear responses exhibit distinct pharmacological profiles.
• Sustained fear responses may serve as a valuable model for studying anxiety and screening anxiolytic agents.
• Pharmacological differentiation supports distinct mechanisms underlying different fear durations.